Alnylam EVP, Chief Legal Officer Laurie Keating resigns, to provide consulting services

ALNYLAM PHARMACEUTICALS, INC.

Laurie Keating, EVP, Chief Legal Officer and Secretary, retired effective Sept 10, 2021 after 7 years.
Entered Letter Agreement for consulting services up to 10 hours/month for 18 months.
Compensation: cash at base rate for 12 months, pro-rata 2021 bonus, health coverage lump sum.
Equity awards continue to vest and remain exercisable during consulting period.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Laurie B. Keating

Executive Vice President, Chief Legal Officer and Secretary

ALNY · ALNYLAM PHARMACEUTICALS, INC.

Effective: 2021-09-10
Filed: September 8, 2021, 7:59 PM ET

On September 6, 2021, Laurie B. Keating, a named executive officer of Alnylam Pharmaceuticals, Inc. (the “Company”), retired from the Company and resigned from her position as Executive Vice President, Chief Legal Officer and Secretary of the Company, effective September 10, 2021, following 7 years of service.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Laurie B. Keating retired as Executive Vice President, Chief Legal Officer and Secretary at ALNYLAM PHARMACEUTICALS, INC..

Action: retired
Role: Executive Vice President, Chief Legal Officer and Secretary

Exact text from the filing

On September 6, 2021, Laurie B. Keating, a named executive officer of Alnylam Pharmaceuticals, Inc. (the “Company”), retired from the Company and resigned from her position as Executive Vice President, Chief Legal Officer and Secretary of the Company, effective September 10, 2021, following 7 years of service.

View on SEC.gov

ALNYLAM PHARMACEUTICALS, INC. filing history →

Source: SEC EDGAR

accession 0001193125-21-267358

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.